The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Path: Pneumoconiosis (silicosis, talcosis, talcoma)
Publications
Non-Infectious Granulomatous Lung Disease: Imaging Findings with Pathologic Correlation.
Korean journal of radiology. 2021;22(8):1416-1435
Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease.
Archives of pathology & laboratory medicine. 2007;131(3):407-23
Pulmonary talcosis: CT findings in three cases.
Radiology. 1993;186(1):125-7
Talc: understanding its manifestations in the chest.
AJR. American journal of roentgenology. 1986;146(2):295-301
Long-term follow-up of drug abusers with intravenous talcosis.
The American review of respiratory disease. 1989;139(1):233-41
Pulmonary 'mainline' granulomatosis: talcosis of intravenous methadone abuse.
Medicine. 1979;58(3):229-39